1. Home
  2. CAPR
  3. CAPR News

Latest Capricor Therapeutics Inc. (CAPR) News on November 25, 2024

CAPR

MT Newswires

4 days ago

Capricor Gets Orphan Drug, Advanced Therapy Medicinal Product Designations for Deramiocel in Europe

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
CAPR

GlobeNewswire

4 days ago

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

CAPR

MT Newswires

6 days ago

JonesTrading Initiates Capricor Therapeutics at Buy Rating With $40 Price Target

Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025?
CAPR

Insider Monkey

9 days ago

Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025?

Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations
CAPR

Simply Wall St.

10 days ago

Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations

CAPR

Thomson Reuters StreetEvents

10 days ago

Q3 2024 Capricor Therapeutics Inc Earnings Call

Capricor Therapeutics (CAPR) Reports Q3 Loss, Misses Revenue Estimates
CAPR

Zacks

11 days ago

Capricor Therapeutics (CAPR) Reports Q3 Loss, Misses Revenue Estimates

CAPR

MT Newswires

11 days ago

Capricor Therapeutics Q3 Net Loss Widens, Revenue Declines From Year-Ago Levels

CAPR

Associated Press Finance

11 days ago

Capricor: Q3 Earnings Snapshot

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
CAPR

GlobeNewswire

11 days ago

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting
CAPR

GlobeNewswire

12 days ago

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting

Is Capricor Therapeutics (CAPR) Outperforming Other Medical Stocks This Year?
CAPR

Zacks

17 days ago

Is Capricor Therapeutics (CAPR) Outperforming Other Medical Stocks This Year?

Prestige Consumer Healthcare (PBH) Meets Q2 Earnings Estimates
CAPR

Zacks

18 days ago

Prestige Consumer Healthcare (PBH) Meets Q2 Earnings Estimates

Verano Holdings Corp. (VRNOF) Expected to Beat Earnings Estimates: Should You Buy?
CAPR

Zacks

18 days ago

Verano Holdings Corp. (VRNOF) Expected to Beat Earnings Estimates: Should You Buy?

Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline
CAPR

Zacks

19 days ago

Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13
CAPR

GlobeNewswire

19 days ago

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

High Growth Tech Stocks to Watch in October 2024
CAPR

Simply Wall St.

a month ago

High Growth Tech Stocks to Watch in October 2024

CAPR

MT Newswires

a month ago

Piper Sandler Initiates Capricor Therapeutics at Overweight With $35 Price Target

CAPR

MT Newswires

a month ago

Capricor Therapeutics Closes Underwritten Public Offering

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
CAPR

GlobeNewswire

a month ago

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

CAPR

MT Newswires

a month ago

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Thursday

CAPR

MT Newswires

a month ago

Capricor Therapeutics Prices $75 Million Common Stock Offering

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock
CAPR

GlobeNewswire

a month ago

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

CAPR

MT Newswires

a month ago

Capricor Therapeutics Starts Public Stock Offering

Capricor Therapeutics Announces Proposed Public Offering of Common Stock
CAPR

GlobeNewswire

a month ago

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

Capricor touts long-term efficacy of DMD therapy ahead of FDA application
CAPR

Clinical Trials Arena

a month ago

Capricor touts long-term efficacy of DMD therapy ahead of FDA application

Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years
CAPR

Benzinga

a month ago

Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years

CAPR

MT Newswires

a month ago

Capricor Reports Positive Data in Duchenne Muscular Dystrophy Study; Shares Rise

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress
CAPR

GlobeNewswire

a month ago

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

Capricor Therapeutics Inc (CAPR) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
CAPR

GuruFocus.com

2 months ago

Capricor Therapeutics Inc (CAPR) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

CAPR

MT Newswires

2 months ago

Capricor Therapeutics Submits Biologics License Application to FDA for Duchenne Muscular Dystrophy Drug Candidate

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
CAPR

GlobeNewswire

2 months ago

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

Does Capricor (CAPR) Have the Potential to Rally 90.16% as Wall Street Analysts Expect?
CAPR

Zacks

2 months ago

Does Capricor (CAPR) Have the Potential to Rally 90.16% as Wall Street Analysts Expect?

CAPR

MT Newswires

2 months ago

Sector Update: Health Care

CAPR

MT Newswires

2 months ago

Capricor to Show Trial Data Over Long-Term Benefits of Deramiocel in DMD; Shares Soar

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress
CAPR

GlobeNewswire

2 months ago

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress

Is Capricor Therapeutics, Inc. (CAPR) the Best Russell 2000 Stock to Buy According to Analysts?
CAPR

Insider Monkey

2 months ago

Is Capricor Therapeutics, Inc. (CAPR) the Best Russell 2000 Stock to Buy According to Analysts?

High Growth Tech Stocks To Watch In September 2024
CAPR

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In September 2024

CAPR

MT Newswires

2 months ago

Oppenheimer Adjusts Capricor Therapeutics Price Target to $43 From $15, Maintains Outperform Rating

CAPR

MT Newswires

2 months ago

Sector Update: Health Care

CAPR

MT Newswires

2 months ago

Cantor Fitzgerald Adjusts Capricor Therapeutics Price Target to $25 From $8, Maintains Overweight Rating; Shares Rise

CAPR

MT Newswires

2 months ago

Capricor Therapeutics to Seek Full Approval of Deramiocel to Treat DMD Cardiomyopathy; Shares Rise

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
CAPR

GlobeNewswire

2 months ago

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

Capricor (CAPR) Surges 18.2%: Is This an Indication of Further Gains?
CAPR

Zacks

2 months ago

Capricor (CAPR) Surges 18.2%: Is This an Indication of Further Gains?

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024
CAPR

GlobeNewswire

2 months ago

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

CAPR

MT Newswires

2 months ago

Oppenheimer Adjusts Capricor Therapeutics Price Target to $15 From $14, Maintains Outperform Rating

CAPR

MT Newswires

2 months ago

Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe

Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
CAPR

GlobeNewswire

2 months ago

Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy

EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm
CAPR

Benzinga

2 months ago

EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm

Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences
CAPR

GlobeNewswire

3 months ago

Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences

Things Look Grim For Capricor Therapeutics, Inc. (NASDAQ:CAPR) After Today's Downgrade
CAPR

Simply Wall St.

3 months ago

Things Look Grim For Capricor Therapeutics, Inc. (NASDAQ:CAPR) After Today's Downgrade

Capricor Therapeutics Second Quarter 2024 Earnings: Beats Expectations
CAPR

Simply Wall St.

4 months ago

Capricor Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates
CAPR

Zacks

4 months ago

Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates

CAPR

Associated Press Finance

4 months ago

Capricor: Q2 Earnings Snapshot

Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
CAPR

GlobeNewswire

4 months ago

Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7
CAPR

GlobeNewswire

4 months ago

Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7

CAPR

MT Newswires

5 months ago

Capricor Therapeutics Joins Russell 3000, Russell 2000 Indexes

Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
CAPR

GlobeNewswire

5 months ago

Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

Capricor’s cell therapy shows three year benefit in DMD patients
CAPR

Clinical Trials Arena

5 months ago

Capricor’s cell therapy shows three year benefit in DMD patients

Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy
CAPR

GlobeNewswire

5 months ago

Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy

CORRECTION: Capricor Therapeutics
CAPR

GlobeNewswire

5 months ago

CORRECTION: Capricor Therapeutics

Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
CAPR

GlobeNewswire

5 months ago

Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy

CAPR

MT Newswires

5 months ago

Sector Update: Health Care Stocks Decline Tuesday Afternoon

CAPR

MT Newswires

5 months ago

Capricor Says FDA Grants Pre-BLA Meeting Request for Duchenne Muscular Dystrophy Treatment; Shares Rise

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
CAPR

GuruFocus.com

5 months ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

CAPR

Energy Global

5 months ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
CAPR

USA TODAY

5 months ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
CAPR

Business Wire

5 months ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
CAPR

Business Wire

5 months ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips
CAPR

GlobeNewswire

5 months ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll
CAPR

Reuters

5 months ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030
CAPR

GlobeNewswire

5 months ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway
CAPR

GlobeNewswire

5 months ago

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway

Capricor (CAPR) Advances in DMD Therapy With Positive Study Data
CAPR

Zacks

5 months ago

Capricor (CAPR) Advances in DMD Therapy With Positive Study Data

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
CAPR

Business Wire

5 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
CAPR

GlobeNewswire

5 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23
CAPR

GlobeNewswire

5 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
CAPR

Simply Wall St.

5 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May
CAPR

Reuters

5 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
CAPR

AFP

5 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed
CAPR

PR Newswire

5 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
CAPR

GlobeNewswire

5 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

US equities open lower on May jobs report
CAPR

Yahoo Finance Video

6 months ago

US equities open lower on May jobs report

The Government of Canada invests over $3.3 million in nine grassroots, community projects to curb greenhouse gas emissions and fight climate change
CAPR

CNW Group

6 months ago

The Government of Canada invests over $3.3 million in nine grassroots, community projects to curb greenhouse gas emissions and fight climate change

CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
CAPR

GlobeNewswire

6 months ago

CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS

CAPR

GlobeNewswire

6 months ago

Onfolio Holdings Inc. To Acquire DDS Rank Business

Thor Equities Group Advances Cross-Border Logistics Strategy with Key Acquisition
CAPR

GlobeNewswire

6 months ago

Thor Equities Group Advances Cross-Border Logistics Strategy with Key Acquisition

As Nvidia Teases Mega Milestone, This AI Stock Targets Early Breakout
CAPR

Investor's Business Daily

6 months ago

As Nvidia Teases Mega Milestone, This AI Stock Targets Early Breakout

See's Candies® Launches New Scotchmallow® Littles
CAPR

PR Newswire

6 months ago

See's Candies® Launches New Scotchmallow® Littles

Biden announces $225 mn in new aid for Ukraine at Paris talks with Zelensky
CAPR

AFP

6 months ago

Biden announces $225 mn in new aid for Ukraine at Paris talks with Zelensky

Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
CAPR

GlobeNewswire

6 months ago

Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy

Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been stellar, earning 113% in 5 years
CAPR

Simply Wall St.

6 months ago

Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been stellar, earning 113% in 5 years

CAPR

MT Newswires

6 months ago

Oppenheimer Initiates Capricor Therapeutics at Outperform Rating

CAPR

GuruFocus.com

6 months ago

Capricor Therapeutics Inc (CAPR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Capricor Therapeutics (CAPR) Reports Q1 Loss, Misses Revenue Estimates
CAPR

Zacks

6 months ago

Capricor Therapeutics (CAPR) Reports Q1 Loss, Misses Revenue Estimates

CAPR

Associated Press Finance

6 months ago

Capricor: Q1 Earnings Snapshot

Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
CAPR

GlobeNewswire

6 months ago

Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
CAPR

GlobeNewswire

7 months ago

Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
CAPR

GlobeNewswire

7 months ago

Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences

Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
CAPR

GlobeNewswire

7 months ago

Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13

Share on Social Networks: